I. Hennig

发表

Oral administration of cannabis with lipids leads to high levels of cannabinoids in the intestinal lymphatic system and prominent immunomodulation

C. Constantinescu, P. Fischer, D. Barrett, 2017, Scientific Reports.

Dietary fats and pharmaceutical lipid excipients increase systemic exposure to orally administered cannabis and cannabis-based medicines.

C. Constantinescu, P. Fischer, D. Barrett, 2016, American journal of translational research.

Adenovirus-mediated hypoxia-targeted gene therapy using HSV thymidine kinase and bacterial nitroreductase prodrug-activating genes in vitro and in vivo

G. Hall, P. Cooper, P. Selby, 2011, Cancer Gene Therapy.

Severe sequence-specific toxicity when capecitabine is given after Fluorouracil and leucovorin.

S. M. Crawford, Julia M. Brown, A. Szubert, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Results of a phase II pilot study of moderate dose radiotherapy for inoperable desmoid-type fibromatosis--an EORTC STBSG and ROG study (EORTC 62991-22998).

S. Gwyther, J. D. de Jong, R. Keus, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Use of blood outgrowth endothelial cells as virus-producing vectors for gene delivery to tumors.

R. Vile, F. Cosset, R. Simari, 2004, American journal of physiology. Heart and circulatory physiology.

Substance‐P receptors in human primary neoplasms: Tumoral and vascular localization

J. Laissue, J. Reubi, U. Horisberger, 1995, International journal of cancer.

Association of the subtype 2 of the Epstein-Barr virus with T-cell non-Hodgkin's lymphoma of the midline granuloma type.

R. Kraft, J. Laissue, B. Borisch, 1993, Blood.

Immune checkpoint inhibitors: current status

A. Wilcock, I. Hennig, A. F. Palma dos Reis, 2021, BMJ supportive & palliative care.

Distribution and localization of Epstein–Barr virus subtypes A and B in AIDS‐related lymphomas and lymphatic tissue of HIV‐positive patients

J. Laissue, B. Borisch, P. Heitz, 1992, The Journal of pathology.

Interleukin-12 expression in human lymphomas and nonneoplastic lymphoid disorders.

M. Fey, A. Tobler, J. Schwaller, 1995, Blood.

Imaging Modality and Frequency in Surveillance of Stage I Seminoma Testicular Cancer: Results From a Randomized, Phase III, Noninferiority Trial (TRISST)

R. Laing, R. Huddart, M. Highley, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Hodgkin's lymphoma of the midline granuloma type (see comments) Association of the subtype 2 of the Epstein-Barr virus with T-cell non-

R. Kraft, J. Laissue, B. Borisch, 2011 .

Enteropathy-associated T-cell lymphoma in a renal transplant patient with evidence of Epstein-Barr virus involvement

F. Horber, J. Laissue, B. Borisch, 2005, Virchows Archiv A.

Imbalance Associated With Cisplatin Chemotherapy in Adult Cancer Survivors: A Clinical Study

D. Hall, D. Baguley, I. Hennig, 2021, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology.

Cediranib in patients with alveolar soft-part sarcoma (CASPS): a double-blind, placebo-controlled, randomised, phase 2 trial

I. Judson, B. Seddon, M. Tattersall, 2019, The Lancet. Oncology.

Is clarithromycin a potential treatment for cachexia in people with lung cancer? A feasibility study.

A. Wilcock, V. Crosby, D. Baldwin, 2017, Lung cancer.

Downregulation of a protective Actinobacillus pleuropneumoniae antigen during the course of infection.

G. Gerlach, I. Hennig, B. Teutenberg-Riedel, 1999, Microbial pathogenesis.

Activity and safety of crizotinib in patients with alveolar soft part sarcoma with rearrangement of TFE3: European Organization for Research and Treatment of Cancer (EORTC) phase II trial 90101 ‘CREATE’

J. Blay, S. Aamdal, R. Sciot, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Expression of TCL1 in Hematologic Disorders

C. Croce, R. Dummer, M. Fey, 2001, Pathobiology.

Extra-abdominal desmoid fibromatosis: A review of management, current guidance and unanswered questions.

A. Gronchi, T. Mcculloch, N. Eastley, 2016, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Local up-regulation of neuropeptide receptors in host blood vessels around human colorectal cancers.

L. Mazzucchelli, J. Laissue, J. Reubi, 1996, Gastroenterology.

Activity and safety of crizotinib in patients with advanced, metastatic alveolar soft part sarcoma (ASPS) with rearrangement of TFE3: European Organization for Research and Treatment of Cancer (EORTC) phase 2 trial 90101 CREATE.

J. Blay, S. Aamdal, A. Italiano, 2018 .

Nationwide trends in the current management of desmoid (aggressive) fibromatosis.

R. Ashford, N. Eastley, C. Esler, 2015, Clinical oncology (Royal College of Radiologists (Great Britain)).

Heritable defects in telomere and mitotic function selectively predispose to sarcomas

Melissa J. Green, Emma M. Rath, R. Redon, 2023, Science.

[Clinical and laboratory diagnostic findings in chronic pleuropneumonia of swine].

K. Waldmann, M. Ganter, G. Gerlach, 1998, Tierarztliche Praxis. Ausgabe G, Grosstiere/Nutztiere.

Developing an integrated rehabilitation model for thoracic cancer services: views of patients, informal carers and clinicians

I. Higginson, M. Maddocks, A. Wilcock, 2018, Pilot and Feasibility Studies.

Maintenance pazopanib versus placebo in Non-Small Cell Lung Cancer patients non-progressive after first line chemotherapy: A double blind randomised phase III study of the lung cancer group, EORTC 08092 (EudraCT: 2010-018566-23, NCT01208064).

V. Georgoulias, P. Baas, T. Čufer, 2015, European journal of cancer.

Long-term outcomes with intensive induction chemotherapy (carboplatin, bleomycin, vincristine and cisplatin/bleomycin, etoposide and cisplatin) and standard bleomycin, etoposide and cisplatin in poor prognosis germ cell tumours: A randomised phase II trial (ISRCTN53643604)

R. Huddart, J. Shamash, S. Stenning, 2020, European journal of cancer.

Salvage Chemotherapy With Gemcitabine, Paclitaxel, Ifosfamide, and Cisplatin for Relapsed Germ Cell Cancer

R. Huddart, G. Rustin, G. Mead, 2018, Clinical genitourinary cancer.

Activity of cediranib in alveolar soft part sarcoma (ASPS) confirmed by CASPS (cediranib in ASPS), an international, randomised phase II trial (C2130/A12118).

I. Judson, B. Seddon, J. Bliss, 2017 .

Loading doses for costly cancer biologicals: a cause for concern or tilting at windmills?

C. Twelves, I. Hennig, 2008, European journal of cancer.

Can body composition be used to optimize the dose of platinum chemotherapy in lung cancer? A feasibility study

V. Baracos, A. Wilcock, V. Crosby, 2017, Supportive Care in Cancer.

99. Nationwide trends in the current management of desmoid (aggressive) fibromatosis

R. Ashford, N. Eastley, C. Esler, 2014 .

A vision for inclusive and transparent health data in the beyond. Learning

M. Tattersall, I. Judson, B. Seddon, 2019 .

Extra-abdominal desmoid fibromatosis: A review of management, current guidance and unanswered questions.

A. Gronchi, R. Ashford, T. Mcculloch, 2016, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.